AI in Medicine

IdeaNavigator AI uses a story about a donated kidney reaching its recipient’s 100th birthday to propose testing a consumer-health signal monitor.

An IdeaNavigator AI concept proposes recovery guidance tailored to delivery details, with a 200-person pilot suggested to assess its use.

IdeaNavigator AI proposes testing a role-focused wellness news monitor. The material does not provide medical guidance or identify five symptoms.

IdeaNavigator AI proposes testing a tracker that links TRT patients’ lab results, dose changes and symptoms; demand and retention remain unproven.

IdeaNavigator AI outlines a proposed GLP-1 pharmacy index for checking dose availability and cash prices. No tracker has been announced as launched.

Researchers at Claude have identified a novel enzyme system featuring CRISPR-like repeats, sparking scientific interest and raising questions about potential applications.

Novo Nordisk’s collaboration with Anthropic signals a shift toward AI-driven drug discovery, impacting healthcare innovation and market dynamics.

Anthropic reports that its Claude AI models are being used by researchers to support biomolecular modeling tasks, including code generation and literature synthesis.

Search interest surges in topics like insane asylums, ECT, lobotomies, Freud & Jung amid renewed debate on mental health history.

University of Pennsylvania uses AI like ChatGPT and Codex to identify potential antimicrobial molecules from genomes, reducing search time from years to hours.